Conference highlights need for innovations in OTC
Organisers CubeX, key speaker Nicholas Hall uncover little known aspects of pharma OTC
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
analytica Anacon India 2013 witnesses leading companies from instrumentation industry
4,022 trade visitors attended the event at Bombay Exhibition Centre
EMPROVE seminar spotlights forthcoming regulatory changes
Features insights, solutions and tools to better cope with the challenges ahead
DigiSights 2013 explores potential of digital & social media in pharma marketing
Speakers highlight need for clarity on regulations in today’schanging environment. Express Pharma was the exclusive media partner
Nobody’s children
Countries have been marking Children’s Day for many years but until very recently, there was hardly any drug development focused…
Spain-based Grifols to acquire Novartis blood transfusion diagnostics unit
Divestiture further enhances Novartis focus on strategic businesses
LifeCell in second phase of expansion at Gurgaon centre
In talks with Haryana and Tamil Nadu state governments for PPP model
Suven Life secures product patents from the US and Japan
The patents are valid through 2026 and 2028
Eisai starts supply of Diethylcarbamazine to eliminate lymphatic filariasis
First shipment to benefit more than 6 million people in four endemic countries
65th IPC to be held at Delhi, NCR
Registration extended to Nov 30, Express Pharma is Official Media Partner
Healthcare Brand Summit on Dec 5
Speakers to discuss changing trends, challenges and their outlook on the future of this industry
CII Pharma Summit reflects on regulatory challenges
Explores how industry can navigate regulatory challenges and chart strategies for growth
6th Nasal and Pulmonary Drug Delivery symposium held in Mumbai
Indian Pharmaceutical Association and Aptar Pharma jointly organise the event
Alliance India organises conference on pharma regulatory & quality compliance
Conference discussed about ongoing regulatory affairs faced by many companies within the pharmaceutical and healthcare sector
M&A activity in pharma market witnesses significant decline in value terms in Oct 2013
In terms of volume, the sector recorded 27 venture funded deals
To FDI or Not to FDI?
As the Health Department mulls over the report of the Parliamentary Standing Committee over FDI in the pharma sector amidst…
Global market for biomarkers is likely to touch $34 billion by 2017
Shalini Gupta finds out more in an interview with Sanjeev Johar, Chief Executive Officer, Alere India
CDSCO approval to market Ranbaxys Synriam in India for treatment of malaria
The phase III clinical trials for the drug conducted in India successfully demonstrated the efficacy and tolerability of Synriam…